[1] |
Chen Meimei, Duan Xiaoyan, Cao Haixia, et al..
Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets
[J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
|
[2] |
Liu Yingchuan, Zhao Pengcheng, You Ting, et al..
Changes of peripheral blood 25-(OH) 2-D3 levels and peripheral T lymphocyte subsets in patients with primary biliary cirrhosis receiving vitamin D supplementation and ursodeoxycholic acid treatment
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 907-910.
|
[3] |
Liu Jinguo, Wang Baokui.
Efficacy of Fufangbiejia Ruanganpian and ursodeoxycholic acid combination in the treatment of patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 340-343.
|
[4] |
Qin Wei, Chen Yuping, Yang Zhao, et al.
Expression of transforming growth factor β-1 in liver tissues of patients with primary biliary cirrhosis and its relationship with liver fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 237-240.
|
[5] |
Chen Xiaojun, Song Yang.
Changes of peripheral blood T lymphocyte subsets and efficacy of ursodesoxycholic acid and vitamin D combination in treatment of patients with primary biliary cholangitis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 80-83.
|
[6] |
Tao Mingling, Zhang Shibin, Wu Yanjing, et al..
Non-invasive predictors of esophageal varices in patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 439-442.
|
[7] |
Liu Funa, Liu Jiangkui, Shen Yihui..
Efficacy of ursodeoxycholic acid and prednisolone combination in treatment of patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 443-446.
|
[8] |
Guo Rui, Tan Jin..
A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 109-110.
|
[9] |
Hao Jianhong,Hao Haiyan,Hu Yiling.
Clinical features of primary biliary cirrhosis: An analysis of 94 cases
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 352-353.
|
[10] |
Zhou Xinren, Wang Fang, Yun Shenghao.
Intrahepatic transplantation of umbilical cord blood stem cells in treatment of patients with decompensated primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 219-220.
|
[11] |
Wang Gui, Wang Jiangbin..
Features of elderly patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 573-574.
|
[12] |
Kong Xianglu,Guo Xiaoxia.
Systemic review of Chinese herbal medicine combined with ursodeoxycholic acid in treatment of patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 379-382.
|
[13] |
Li Pingying,Lu Lungen.
Advances in pharmacotherapy of patients with primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 441-444.
|
[14] |
Chen Jing, Jia Gui, Gao Zhengjun, et al..
Smoking and primary biliary cirrhosis:A case-control study
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 164-167.
|
[15] |
Su Lan, Yang Jinhui.
T helper type 17 and T regulatory cells in primary biliary cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 213-216.
|